Chemoembolization, Therapeutic clinical trials at UC Cancer

1 research study open to eligible people

Contrast-enhanced Ultrasound Evaluation of Chemoembolization
open to eligible people ages 21 years and up
The primary objective of this trial is to evaluate the sensitivity and specificity of 2D and 4D contrast enhanced ultrasound for monitoring transarterial chemoembolization (TACE) response 1-2 weeks and 1 month post treatment as an alternative to contrast-enhanced magnetic resonance (MRI) or computed tomography (CT) imaging
at UCSD

Last updated: August 2021